Management of congestive heart failure: How well are we doing?

Giannetti, Nadia
August 2001
CMAJ: Canadian Medical Association Journal;8/7/2001, Vol. 165 Issue 3, p305
Academic Journal
Offers observations on the management of congestive heart failure (CHF) by Canadian physicians. Guidelines which have been established for the evaluation and treatment of CHF; Reasons for incidents of the underusage and underdosage of angiotensin-converting enzyme inhibitors; Reference to an article by Weil and Tu in this issue; Suggestion that there are rational and cost-effective solutions which meet the increased prevalence of CHF.


Related Articles

  • Quality of congestive heart failure treatment at a Canadian teaching hospital. Weil, Evette; Tu, Jack V. // CMAJ: Canadian Medical Association Journal;8/7/2001, Vol. 165 Issue 3, p284 

    Interpretation: Most patients who had CHF at this Canadian hospital received left ventricular function testing and ACE inhibitor therapy. Future educational efforts should focus on the importance of adequate dosing of ACE inhibitors.

  • Are Angiotensin-II Antagonists Effective in CHF Treatment? Miller, Karl E. // American Family Physician;10/15/1999, Vol. 60 Issue 6, p1812 

    Presents an abstract of the study `Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure,' by E. P. Havranek et al., from April 1999 issue of the `Journal of American College Cardiology.'

  • Success of a P&T policy for use of a second ACE inhibitor before switching to an ARB.  // Formulary;Feb2002, Vol. 37 Issue 2, p97 

    Focuses on the use of ACE inhibitor therapy for treatment of congestive heart failure in Miami, Florida. Development of policy by Miami VA Medical Center's P & T Committee for the use of ACE inhibitors; Association of captopril and enlapril with highest incidence of cough; Use of Angiotensin II...

  • Race, Medicine, and the Science Behind BiDil: How ACE-Inhibition Took the Fall for the First Ethnic Drug. Kaufman, Jay; Nguyen, Thu; Cooper, Richard // Review of Black Political Economy;Jun2010, Vol. 37 Issue 2, p115 

    A substantial biomedical literature has accumulated around the question of racial differences in the response to treatment with angiotensin converting enzyme (ACE) inhibitors for hypertension and congestive heart failure. African-origin populations are often asserted to be “low...

  • Effects of ACE inhibitors in congestive heart failures.  // American Family Physician;10/1/1995, Vol. 52 Issue 5, p1506 

    Reports on a study from the May 10, 1995 issue of the `Journal of the American Medical Association,' by Garg and colleagues who reviewed a variety of studies that examined the effect of ACE inhibitors on morbidity and mortality from congestive heart failures. Reduction of deaths and...

  • Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels. Ajmal, Adnan; Gessert, Charles E.; Johnson, Brian P.; Renier, Colleen M.; Palcher, Jeanette A. // BMC Research Notes;2013, Vol. 6 Issue 1, p1 

    Background Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are widely used in the management of congestive heart failure (CHF), diabetes mellitus (DM) and hypertension (HTN). Use of these agents is reported to cause anemia. Methods We examined the...

  • fosinopril.  // Royal Society of Medicine: Medicines;2002, p257 

    The article presents information on fosinopril. The drug is an ACE inhibitor and acts as a vasodilator. It can be used as an antihypertensive and as a congestive heart failure treatment often when other treatments cannot be used. It is frequently administered in conjunction with other classes of...

  • Angiotensin II Antagonist Had No Survival Benefit over an ACE Inhibitor in Elderly Patients with Congestive Heart Failure but Was Better Tolerated. B., Pitt; P.A., Poole-Wilson; R., Segal; Frishman, William H. // Annals of Internal Medicine;9/18/2001, Vol. 135 Issue 6, p443 

    Compares the efficacy of angiotensin II antagonists and angiotensin converting enzyme (ACE) inhibitors in treating congestive heart failure. Effects of ACE inhibitors on bradykinin levels; Estimation of the average annual rates of all-cause mortality; Elimination of the cough in a patient taking...

  • First-line therapy for CHF. Yacone-Morton, Linda Ann; Hurley, Mary Lou // RN;Feb95, Vol. 58 Issue 2, p38 

    Part I. Looks at the use of diuretics and angiotensin converting enzyme (ACE) inhibitors in treating congestive heart failure (CHF). Factors contributing to CHF; Role of diuretics and ACE inhibitors in reducing stress on the heart; Guidelines from the Agency for Health Care Policy and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics